Centerpoint Advisors’s Chemours CC Stock Holding History

Centerpoint Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40	Closed	-$1K	–	486
2022 Q3	$1K	Sell	40 -100	-71%	-$3.3K	﹤0.01%	344
2022 Q2	$4K	Buy	140 +70	+100%	+$2.58K	﹤0.01%	279
2022 Q1	$2K	Hold	70	–	–	﹤0.01%	314
2021 Q4	$2K	Hold	70	–	–	﹤0.01%	329
2021 Q3	$2K	Hold	70	–	–	﹤0.01%	250
2021 Q2	$2K	Hold	70	–	–	﹤0.01%	251
2021 Q1	$2K	Hold	70	–	–	﹤0.01%	227
2020 Q4	$2K	Hold	70	–	–	﹤0.01%	219
2020 Q3	$1K	Hold	70	–	–	﹤0.01%	215
2020 Q2	$1K	Hold	70	–	–	﹤0.01%	256
2020 Q1	$1K	Hold	70	–	–	﹤0.01%	230
2019 Q4	$1K	Hold	70	–	–	﹤0.01%	256
2019 Q3	$1K	Hold	70	–	–	﹤0.01%	253
2019 Q2	$2K	Hold	70	–	–	﹤0.01%	235
2019 Q1	$3K	Hold	70	–	–	﹤0.01%	211
2018 Q4	$2K	Hold	70	–	–	﹤0.01%	214
2018 Q3	$3K	Hold	70	–	–	﹤0.01%	198
2018 Q2	$3K	Hold	70	–	–	﹤0.01%	241
2018 Q1	$3K	Hold	70	–	–	﹤0.01%	194
2017 Q4	$4K	Buy	+70	New	+$3.67K	﹤0.01%	167

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Centerpoint Advisors's CC Position: Q4 2022 in Review

Centerpoint Advisors sold out of Chemours (CC) in Q4 2022, closing a stake of 40 shares — an estimated $1K sold.

Centerpoint Advisors first reported a position in CC in Q4 2017 and held it in 20 quarters. The position peaked at $4K in Q2 2022. 473 funds tracked by Wall St. Rank hold CC as of Q4 2022.

Centerpoint Advisors reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
Centerpoint Advisors sold 40 Chemours shares in Q4 2022, an estimated $1K.
Centerpoint Advisors first reported a position in Chemours in Q4 2017 and held it in 20 quarters.
Centerpoint Advisors's Chemours position peaked at $4K in Q2 2022.
473 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on Centerpoint Advisors's 13F filing for Q4 2022, filed 24 Jan 2023.